✦ LIBER ✦

Progress resulting from clinical trials: Solid tumors in childhood cancer

✍ Scribed by John N. Lukens

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 962 KB
Volume: 74
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19941101)74:9+<2710::aid-cncr2820741821>3.0.co;2-g

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Childhood cancer in the united states: A

Childhood cancer in the united states: A geographical analysis of cases from the Pediatric Cooperative Clinical Trials Groups

✍ Julie A. Ross; Richard K. Severson; Brad H. Pollock; Leslie L. Robison 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 648 KB

## BACKGROUND. After injuries, cancer is the leading cause of death in children younger than 15 years in the IJnited States. Despite dramatic increases in .?-year survival rates, more than 100,000 person-years of life are lost to childhood cancer each year. 'The exact proportion of pediatric cance

Tumor size and regional lymph node metas

Tumor size and regional lymph node metastasis in colorectal cancer a preliminary analysis from the NSABP clinical trials

✍ Norman Wolmark; Ildefonso Cruz; Carol K. Redmond; Bernard Fisher; Edwin R. Fishe 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 640 KB

This study explores the relationships between tumor size and regional lymph node involvement in patients with Dukes' B and C colorectal cancer in the randomized prospective clinical trials of the NSABP. Six-hundred and seventy patients with colon cancer and 236 patients with carcinoma of the rectum

Report from the International Union Agai

Report from the International Union Against Cancer (UICC) Tumor Biology Committee : UICC workshop on the use of dendritic cells in cancer clinical trials

✍ Michael L. Salgaller; Martin Thurnher; Georg Bartsch; Alton L. Boynton; Gerald P 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

Cancer (UICC) Tumor Biology Committee to evaluate the results of dendritic cell-based immunotherapy for cancer patients. Suggested reading about this therapy is listed in the References. [1][2][3][4][5][6][7][8][9][10] The following are the recorded results of the workshop discussions. Individual pr

Vorinostat in advanced prostate cancer p

Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862) : Trial results and interleukin-6 analysis: A study by the Department of Defense Prostate Cancer Clinical Trial Consortium and University of Chicago Phase 2 Consortium

✍ Deborah Bradley; Dana Rathkopf; Rodney Dunn; Walter M. Stadler; Glenn Liu; David 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

A phase II study of carboplatin in child

A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the childrens cancer group

✍ Lawrence J. Ettinger; Paul S. Gaynon; Mark D. Krailo; Ning Ru; Edward S. Baum; S 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 3 views

Background. Carboplatin is an analogue of cisplatin with less nonhematologic toxicity than

A dose-intensive, cyclophosphamide-based

A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/Progressive or advanced solid tumors of childhood : A report from the Australia and New Zealand Children's Cancer Study Group

✍ Paul A. Carpenter; Les White; Geoffrey B. McCowage; Vimala Nayanar; Ian Toogood; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 3 views

promising salvage regimen. Continued accrual of patients and increased duration of follow-up has resulted in substantial experience with VETOPEC.